chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Case number PHEH2013US007281 is an initial spontaneous report received from a pharmacist on 26 Mar 2013. This case refers to a 38-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with an expired MENVEO vaccine (batch number: A10133, expiration date: Feb 2013 for MenA and Sep 2013 for MenCYW-135) intramuscularly on 26 Mar 2013. No adverse events were reported following this administration error. No other information was available.
tested positive for Covid-19 infection; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 001C21A) for COVID-19 vaccination.     No medical history was not provided by reporter.  Concomitant products included METHOTREXATE, FOLIC ACID, calcium, MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE], CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), cranbberry pills and MILK THISTLE [SILYBUM MARIANUM] for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, SARS-CoV-2 test positive: (Positive) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-085639 (Patient Link).
3/31 5PM - vaccine administered 4/1  12AM - 9AM - unable to sleep 4/1  9AM - 12AM - fatigued, slept all day, developed 101 fever, took Tylenol twice  4/2 9AM - swollen right under-eye 4/2 12PM - swollen right lower lip
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 28-SEP-2014, the patient was vaccinated with a first dose of PNEUMOVAX 23 (dose, route of administration, lot#, expiration date and indication were not reported). Concomitant therapy was not provided. On 04-OCT-2015, the patient was inadvertently vaccinated with another dose of PNEUMOVAX 23 (lot # L022795, expiration date 05-NOV-2016; dose, route of administration and indication were not reported). No adverse effect was reported. Additional information has been requested.
Patient developed severe motor tics 2 hours post-vaccination, followed by a fever and vomiting. Her motor tics have yet to subside. She was completely fine prior to receiving the vaccine.
Child c/o itch at site of vaccine. Later that eve, mom noted swelling in same area. Advised ice TID to QID. Benadryl prn itch. RTC if increased swelling or decreased use of arm.
Anaphylactic reaction: 911 dispatched: IV diphenhydramine administered by EMS;  patient stable/coherent and transported to local hospital.
Subsequent to receiving one dose of varicella virus vaccine live, the pt experienced chickenpox. She was covered with chickenpox all over her body and extremities, in her mouth and in the vaginal area. Some were scabbed, some were postulated. Pt also experienced a fever.
Headache, Myalgia, Arthralgia, Fever & NauseaVomiting Narrative:  Employee reported adverse events lasted for 2 to 2.5 days then resolved
Patient reports feeling localized pain at injection site and eventual development of a "bubble" under the skin. When patient put pressure on the area, clear fluid burst and ran down her arm.
This spontaneous report as received from a health care worker refers to a patient of unknown age and gender. On 06-NOV-2014, the patient was vaccinated with (Oka/Merck) VARIVAX vaccine 0.5 ml, subcutaneous (lot # and expiry date not reported). No concomitant medication was reported. It was reported that the patient received the (Oka/Merck) VARIVAX vaccine which on an unknown date underwent a supported temperature excursion. No adverse experience reported. The outcomes of the events were unknown. A product quality complaint (PQC) was not involved. Additional information has been requested.
This spontaneous report was received from a physician concerning a 79 year old male patient with high cholesterol who on 23-AUG-2012 was vaccinated with a dose of ZOSTAVAX (route, lot number and expiration date were not provided). No other co-suspects were reported. Concomitant medications included pravastatin and finasteride. On 29-AUG-2012 the patient experienced red circle developed at injection site when he received ZOSTAVAX. No treatment information was reported. The outcome of red circle developed at injection site when he received ZOSTAVAX was unknown. Additional information had been requested.
I started chills; Shaking; headache; running 100.9 fever; This case was reported by a consumer via call center representative and described the occurrence of chills in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced chills, tremor, headache and fever. On an unknown date, the outcome of the chills, tremor, headache and fever were recovered/resolved.   It was unknown if the reporter considered the chills, tremor, headache and fever to be related to Shingrix.  Additional case details were reported as follows: The age at the vaccination was not reported. The patient received Shingrix and started chills, shaking, headache, and running fever.  The reporter stated that the symptoms were much milder. For tolerances of 2nd dose, refer case US2019AMR218030, reported by same reporter.
This is a spontaneous report received from contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 45-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The event "seizures" required physician office visit (Ask Doctor for tests/record). Therapeutic measures were taken as a result of seizure, loss of consciousness, chills, confusional state, feeling abnormal, emotional disorder, headache, musculoskeletal stiffness, joint stiffness, nerve injury, myalgia, illness. Therapeutic measures were not taken as a result of dyskinesia, pain in extremity, arthralgia.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Woke up Sunday February 14th with flu like symptoms, transient nausea, weak and tired.  My left arm was tingling from the elbow down to the side of my hand and my ring and little fingers and palm of my hand were numb.  The tingling in my left arm has not stopped since then, my left elbow is sore to the touch and the two fingers tingle and are numb.  The flu symptoms subsided by the following day but the numbness and tingling in my left hand has continued.
He got his vaccine, he had bad headaches, joint aches all over his body from his toes, every joint hurt.  He was in a brain fog and almost like he was dizzy all the time.  Also could not breath and down for 2 months.   Had a headache every day for 2 months, which continues, and never has headaches, and never takes anything for them if he gets them.  He still gets the headaches in the back of his head.  He went to the doctor within 2 months of the vaccine as he continued to feel bad.  He wanted to put him in the hospital and did a COVID test as the gentleman felt it was due to the vaccine, and the test came back negative.  He got a chest x-ray as he could not breath and it came back as him being diagnosed with emphysema and had a previous chest x-ray within 6 months prior to that and it was normal/clear.  He had been on Albuterol in the past and he put him on Symbicort and other inhalers which have not helped.  He also put him on allergy pills as well, which did not help (Claritin), which nothing makes him breathe easier.  He was supposed to get a nebulizer but the doctor has not sent the prescription in to the pharmacy.  He has been having pain in his hands and knees, which he has a history of knee surgeries but nothing helps with that.  His hands also have been swelling and had x-rays of his right hand as he could not use his hand, and those tests showed that the blood has stopped going to his hands.  He went to a hand specialist who said it wasn't carpal tunnel and that there was nothing that they could do for it.  The MRI showed again that he had no blood flowing to his hand.  It showed 3 of his bones that are really dense, and that conclusion is that the blood supply stopped going to his hands.  He has never had a problem with his hands before.   His left hand is now affected now, it was not before and now has started bothering him about a month or two ago.  His wrist is so bad that he cannot hold a cup of coffee or turn a door knob without pain.  Everything he does with it causes pain.  He thinks that something got set off on him, which triggered something for it to be spreading to his joints.  He has not done anything different, does not drink or take any medications other than what is prescribed.  He has not done anything to it to cause any pain, he is right handed dominant and has nothing done to cause this type of pain. It is hurting on the back of his hand and the wrist.    He is now thinking that maybe he needs to see another type of specialist as he is continuing to have pain in many of his joints, which he knows what causes the knee pains due to those injuries and now he just has constant pain.  He feels the situation and pain is spreading, now including his elbows and is worried that since it is quick all of a sudden that where else is it going to spread.
itchiness and redness; itchiness and redness; swelling & soreness on her arm; swelling & soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling & soreness on her arm), PAIN IN EXTREMITY (swelling & soreness on her arm), PRURITUS (itchiness and redness) and ERYTHEMA (itchiness and redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced SWELLING (swelling & soreness on her arm) and PAIN IN EXTREMITY (swelling & soreness on her arm). On 09-Mar-2021, the patient experienced PRURITUS (itchiness and redness) and ERYTHEMA (itchiness and redness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency. On 26-Feb-2021, SWELLING (swelling & soreness on her arm) and PAIN IN EXTREMITY (swelling & soreness on her arm) had resolved. At the time of the report, PRURITUS (itchiness and redness) and ERYTHEMA (itchiness and redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported Treatment information alo included  ice.
Muscle and joint stiffness so severe patient could barely walk. Malaise - stomach and headache, fatigue swollen ankles. Above symptoms began evening of 7-14-2013 and continued for approximately one month with daily improvement beginning 7-20-13.
Noted approximately 2100 2/25/08 noted soreness and warmth at injection site.  The next morning noted swelling, warm to touch, soreness, and when lifting arm away from body site is painful.  Injection site has a "pimple" like spot.  Didn't check for fever at home.
Pt became nauseated with increased BP of 169/110 pulse 89 had dry heaves and refused ambulance. later went to ER
shot 1 in Nov 2020, not yet received shot 2; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in November 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
Patient went to the ER with chest pains.  He was treated and encouraged not to have his second shot.  They did not find anything that the patient was aware of.
Swelling, redness (about 3 inches in diameter), pain, itching at injection site This improved after about 5 days but has worsened again with more redness than before
Information has been received from a physician concerning a 15 year old female who on an unspecified date was vaccinated with GARDASIL and lost her vision in "2007". The physician was not the patient's provider. The physician found this case out from a ski instructor who taught blind children. The event was reported as disabling. Attempts are being made to verify the existence of an identifiable patient and reporter have been unsuccessful. No further information is available.
IT IS NOT A SIDE EFFECT THE PATIENT RECEIVED A VACCINE OUT OF RANGE OF TEMPERATURE STORAGE
worsening of alopecia universalis; patient pregnant during original vaccination. booster dose 3 months post-partum and then worsening alopecia occured
Itchiness at site  vaccine given, right arm.  Redness and skin warm, inflamed, at site vaccine given.
Psoriasis; migraine headaches that she used to get in the past; migraine headaches that she used to get in the past; she is allergic to the other ingredients in the vaccine. Had a reaction that went on for months.; used to be able to walk 2-3 miles without getting winded, but she cannot do that anymore; Tiredness; She was falling asleep during the day; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team for a Pfizer sponsored program. The reporter is the patient. A 70-year-old female patient (reported as currently 71-year-old) received bnt162b2 (BNT162B2), administered in arm left, administration date 19May2021 (Lot number: EW0161) at the age of 70 years as dose 1, single for covid-19 immunisation. Relevant medical history included: chronic lymphocytic Leukemia [CLL] (unspecified if ongoing), notes: doesn't know exactly when she was diagnosed but it was the early part of 2000-2003. Not severe case; and migraine headaches. The patient's concomitant medications were not reported. It was reported that the patient had an allergic reaction to the other ingredients in the vaccine that went on for months. The patient inquired if there was another way to get the messenger RNA into a patient without taking the vaccine. She mentioned that it reactivated problems she had in the past (unspecified). She developed psoriasis which was not a real severe case. She cannot be certain that she could attribute it to the vaccine. She started with migraine headaches that she used to get in the past. She had extreme tiredness. She was falling asleep during the day. She used to be able to walk 2-3 miles without getting winded, but she cannot do that anymore. She had a Total lock down because she had chronic lymphocytic Leukemia CLL. She can walk now, but it took several months or so (maybe took two months). She didn't keep records of exact dates. At that point, she didn't want to get another shot. It was like after one problem something else would pop up. It was mostly minor, but it really bothered her at the time. Since it went away, she has considered it minor. She didn't have a prescribing doctor. She told the doctor about it because she asked him and question. She has had no other vaccines. She has never received a flu shot. She started having side effects the next morning (20May2021). She feels like she has mostly recovered but she is not sure for sure. She did not have laboratory test done. The outcome of the events daytime sleepiness and were recovered on an unspecified date, as for the event allergic reaction to drug excipient was not recovered while the outcome of the other events was unknown.
Facial rash itchy 15 min after administration - Given 50 mg BENADRYL elixir P.O. after 30 min all rash and itchiness resolved. Father told to call 911 if signs returned and check in w/school nurse tomorrow.
it was rpt pt was vax in aug97 & in feb99 pt presented to MD ofc w/chickenpox
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 36 year-old female patient received bnt162b2 (BNT162B2), administered in arm right (Batch/Lot number: unknown) at the age of 36 years as dose 1, single and administered in arm right (Batch/Lot number: unknown) as dose 2, single for Covid-19 immunisation. Relevant medical history included: "She is disabled and has been disabled since birth" (unspecified if ongoing). Family history included: "3 of her grandparents died of cancer" (unspecified if ongoing). There were no concomitant medications. The following information was reported: TASTE DISORDER (non-serious) with onset Mar2021, outcome "not recovered", described as "Messed up taste buds". Additional information: The patient stated after vaccination next day in the evening she messed up her taste buds. It is like food she was used to eating, she can't even eat it. She can still taste, but it doesn't taste good. The patient stated that she works with over 200 kids. No any other product received. No any additional Vaccines administered on Same Date of the Pfizer Suspect. No any vaccine received prior Vaccinations (within 4 weeks). No any AE following prior vaccinations. No relevant Tests was performed. The event did not cause Emergency Room or Physician Office visit. The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
The pt developed small raised dots all over the body and larger red inflammed areas inside the raised red doted area. No respiratory problems, no wheezing or any other symptoms but itches severely.
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ (lot # L008054, expiration date: 30-NOV-2016) (dose and route of administration were not reported). No symptoms were reported. Administered doses of vaccine experienced the temperature excursion of 0 degrees Celsius for 6 days. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Body aches; Chills; 101.9 temp; This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6204), via an unspecified route of administration in the left arm on 23Mar2021 at 14:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included amlodipine 5 mg (MANUFACTURER UNKNOWN) and valsartan 80 mg (MANUFACTURER UNKNOWN), for unknown indications from unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021 at 14:00, the patient experienced chills, body aches and had 101.9 temp. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events chills, body aches and 101.9 temp. The clinical outcomes of the events chills, body aches and 101.9 temp were unknown.   No follow-up attempts are needed. No further information is expected.
Left supraclavicular and left axillary adenopathy. CT scan of chest on 01/14/2021 supported that the lymph nodes looked reactive in nature. The patient was reassured and he is being observed with follow planned for 02/01/2021.
bubble on the skin and then a lot of blood upon removal of the needle; wrong technique in product usage process; This case was reported by a pharmacist via call center representative and described the occurrence of injection site hemorrhage in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 454S2, expiry date 5th November 2021) for prophylaxis.   On 23rd July 2020, the patient received Shingrix (intramuscular). On 23rd July 2020, immediately after receiving Shingrix, the patient experienced injection site hemorrhage and wrong technique in product usage process. On an unknown date, the outcome of the injection site hemorrhage and wrong technique in product usage process were unknown.   The reporter considered the injection site hemorrhage to be related to Shingrix.  Additional details were reported as follows: The patient upon injection into the arm there was a lot of pressure behind the syringe and then after injected in the arm, it caused kind of bubble on the skin and then bleeding upon removal of the needle, which led to wrong technique in product usage process. The pharmacist stated that was sure the injection was intramuscularly. The reporter consented to follow up. This case linked with US2020140271, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020140271:same reporter
This is a spontaneous report received from a contactable consumer or other non-HCP. A 32-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# ET7533), at the age of 32, on Mar 27, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient had tinnitus, onset Apr 11, 2021, with outcome of unknown. No therapeutic measures taken as a result of tinnitus. Additional information: Reporter stated, "Yes, he had tinnitus/ringing in his ear." No follow-up attempts possible. No further information expected.
'entire body adversely affected,'pain arm/hand w/protruding veins/swelling elbow to fingers,stiff/sore neck glands/ha;flashing colors lights in eyes;stomach cramps, n&d,burning condition in kidneys;inability to walk; 'nervous system chaos'
Presents to ED with shortness of breath, history of COPD on home oxygen, noticed to progress over last 2 weeks.  Patient was given IV corticosteroids and IV antibiotics then switched to oral once improved.  Discharged on steroid taper and chronic antibiotics with follow up needed for left subclavian.